Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice

Δ(9)-Tetrahydrocannbinol (THC), the primary active constituent of Cannabis sativa, has long been known to reduce opioid withdrawal symptoms. Although THC produces most of its pharmacological actions through the activation of CB(1) and CB(2) cannabinoid receptors, the role these receptors play in red...

詳細記述

保存先:
書誌詳細
主要な著者: Ramesh, Divya, Ross, Gracious R., Schlosburg, Joel E., Owens, Robert A., Abdullah, Rehab A., Kinsey, Steven G., Long, Jonathan Z., Nomura, Daniel K., Sim-Selley, Laura J., Cravatt, Benjamin F., Akbarali, Hamid I., Lichtman, Aron H.
フォーマット: Artigo
言語:Inglês
出版事項: The American Society for Pharmacology and Experimental Therapeutics 2011
主題:
Behavioral Pharmacology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186294/
https://ncbi.nlm.nih.gov/pubmed/21719468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.111.181370
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料